Neumann, Manuela http://orcid.org/0000-0002-6232-4057
Frick, Petra
Paron, Francesca
Kosten, Jonas
Buratti, Emanuele
Mackenzie, Ian R.
Funding for this research was provided by:
NOMIS Stiftung
AriSLA (PathensTDP)
CIHR
ALS Canada-Brain Canada
Article History
Received: 12 July 2020
Revised: 28 July 2020
Accepted: 1 August 2020
First Online: 10 August 2020
Change Date: 3 November 2020
Change Type: Correction
Change Details: Due to a mistake with incorrect assignment of the originally planned amino acid residues 368-379 to the protein sequence of TDP-43 for antibody production by the contracted company, a peptide corresponding to amino acids 362-373 with a phosphorylated serin at 369 instead of a peptide corresponding to amino acids 368-379 with a phosphorylated serin at 375 was synthesized and used for antibody generation and purification.